AMLX — Amylyx Pharmaceuticals, Inc. stock price, charts and financials

QT72Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
21.87
+1.70+8.43%
OverviewShort InterestFilings
AMLXQT72Amylyx Pharmaceuticals, Inc.·NASDAQ
21.87+8.43%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 13, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
May 26, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026ARSAnnual report to shareholders
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 24, 20268-KCurrent report
Mar 09, 20264Statement of changes in beneficial ownership
Mar 09, 20264Statement of changes in beneficial ownership
Mar 09, 20264Statement of changes in beneficial ownership
Mar 09, 20264Statement of changes in beneficial ownership
Mar 09, 20264Statement of changes in beneficial ownership
Mar 04, 20264Statement of changes in beneficial ownership
Mar 04, 20264Statement of changes in beneficial ownership
Mar 04, 20264Statement of changes in beneficial ownership
Mar 04, 20264Statement of changes in beneficial ownership
#1 / 25 of 358
Page
▼
/ 15